Stock listing

NASDAQ:RDEA Ardea Biosciences Inc Stock

Follow Ardea Biosciences Inc into a list and get an email when it puts out news.

Last close · NASDAQ:RDEA

$31.96 USD

Close on Jun 19, 2012 · No longer trades

Mar 28, 2000 to last close -83.1% · monthly closes, Mar 28, 2000 – Jun 19, 2012
Lowest – highest close
$1.71 – $382.65 USDSince Mar 28, 2000 · lowest May 15, 2003 · highest Jul 10, 2000

Delisted NASDAQ:RDEA no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:RDEA
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Ardea Biosciences Inc on 6ix

Decks
24 decks · latest Jan 9, 2012

Decks

DeckKindSlidesDate
Corporate Update (January 2012)Corporate update56 slidesJan 9, 2012
Corporate Update (November 2011)Corporate update49 slidesNov 7, 2011
Technical Presentation (September 2011)Technical6 slidesSep 7, 2011
Annual European Congress of Rheumatology EULAR 2011Conference34 slidesMay 25, 2011
Corporate Update (January 2011)Corporate update13 slidesJan 6, 2011
Corporate Update (November 2010)Corporate update37 slidesNov 8, 2010
Annual European Congress of Rheumatology EULAR 2010Conference22 slidesJun 18, 2010
Corporate Update (May 2010)Corporate update35 slidesMay 10, 2010
Corporate Update (March 2010)Corporate update27 slidesMar 8, 2010
Corporate Update (January 2010)Corporate update40 slidesJan 11, 2010
All 24 decks
DeckKindSlidesDate
Corporate Update (December 2009)Corporate update37 slidesDec 1, 2009
Corporate Update (November 2009)Corporate update34 slidesNov 3, 2009
Corporate Update (October 2009)Corporate update25 slidesOct 19, 2009
Corporate Update (September 2009)Corporate update40 slidesSep 11, 2009
Investor Day (April 2009)Investor day70 slidesApr 20, 2009
Corporate Update (March 2009)Corporate update37 slidesMar 16, 2009
Corporate Update (January 2009)Corporate update35 slidesJan 16, 2009
Corporate Update (December 2008)Corporate update35 slidesDec 18, 2008
Shareholder Meeting (May 2008)Shareholder meeting34 slidesMay 23, 2008
Corporate Update (March 2008)Corporate update28 slidesMar 18, 2008
Investor Presentation (December 2007)Investor deck38 slidesDec 20, 2007
Corporate Update (November 2007)Corporate update34 slidesNov 28, 2007
Corporate Update (September 2007)Corporate update42 slidesSep 4, 2007
Intrabiotics Pharmaceuticals — Investor Presentation (February 2003)Investor deck19 slidesFeb 18, 2003

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Felix Baker
Other companies: BeOne Medicines Ltd. Class A (Director · Since at least Nov 6, 2026); Denali Therapeutics Inc. (Director · Since at least Jun 3, 2025); Replimune Group, Inc. (Director · Since at least Mar 5, 2025); Bicycle Therapeutics PLC (Director · Since at least Apr 18, 2024); Kymera Therapeutics, Inc. (Chairman · Since at least Mar 28, 2024); vTv Therapeutics Inc. (Director · Since at least Feb 27, 2024); Madrigal Pharmaceuticals, Inc. (Director · Since at least Jun 15, 2023); TScan Therapeutics, Inc. (Director · Since at least Jul 15, 2021); DBV Technologies SA (Director · Since at least Jan 1, 2021); Prelude Therapeutics Incorporated (Director · Since at least Mar 27, 2020); IGM Biosciences Inc (Director · Since at least Sep 17, 2019); Kodiak Sciences Inc (Director · Since at least Oct 3, 2018); Kiniksa Pharmaceuticals International, plc (Lead Director · Since at least Feb 9, 2018); ACADIA Pharmaceuticals Inc. (Director · Since at least Jan 18, 2013); Incyte Corporation (Director · Since at least Jan 4, 2008); Immunocore Holdings plc (Director · May 28, 2024 – May 15, 2025 · Past); Spyre Therapeutics, Inc. (Director · Feb 23, 2021 – Jun 8, 2021 · Past); Talis Biomedical Corp (Director · Nov 2, 2020 – Jun 9, 2023 · Past); Zymeworks Inc. (Director · Mar 16, 2020 – May 8, 2020 · Past); Neurogene Inc. (Director · May 8, 2017 – Dec 18, 2023 · Past); Alexion Pharmaceuticals Inc (Director · Jun 22, 2015 – May 14, 2020 · Past); Aceragen Inc. (Director · Mar 10, 2014 – Apr 1, 2019 · Past); Synageva BioPharma Corp (Director · Aug 14, 2007 – Jun 22, 2015 · Past); Neurogen Corp (Director · Jun 7, 2007 – Jul 25, 2008 · Past); Seagen Inc (Director · May 25, 2007 – Dec 14, 2023 · Past); Genomic Health Inc (Director · May 21, 2007 – Oct 1, 2019 · Past)
Director · Feb 8, 2010 – Jun 19, 2012 · Past
Craig Johnson
Other companies: Aurinia Pharmaceuticals Inc (Board Director · Since at least Nov 7, 2024); Heron Therapeutics, Inc. (Lead Independent Director · Since at least Jan 10, 2014); La Jolla Pharmaceutical Co (Director · Oct 14, 2013 – Aug 22, 2022 · Past); PURE Bioscience (Chief Financial Officer · Aug 1, 2011 – Aug 1, 2011 · Past); DMK Pharmaceuticals Corporation (Director · Feb 10, 2011 – Oct 16, 2013 · Past)
Director · Jan 3, 2011 – Jun 19, 2012 · Past
Kimberly Manhard
Other companies: Connect Biopharma Holdings Limited (CHIEF DEVELOPMENT OFFICER · Since at least Nov 5, 2026); Inhibrx Biosciences, Inc. (Director · Since at least May 24, 2024); Inhibrx Inc (Director · Aug 18, 2020 – May 30, 2024 · Past); Heron Therapeutics, Inc. (EVP, Drug Development · Jan 10, 2014 – Apr 13, 2023 · Past)
SVP, Regulatory & Dev Ops · Oct 28, 2011 – Jun 19, 2012 · Past
David T Hagerty
Other companies: Histogen Inc (EVP, Clinical Development · Oct 1, 2014 – Feb 7, 2019 · Past)
Senior VP & CMO · Dec 16, 2011 – Jun 19, 2012 · Past
Denis HickeyChief Financial Officer · Apr 26, 2007 – Dec 13, 2007 · Past

Open People

Log in to ask 6ix AI your own questions about Ardea Biosciences Inc.